|
About Aradigm
Business Overview
 Leadership
|
Pioneering Advancements in the Pulmonary
Pharmaceutical Industry
Aradigm's
team represents a rare combination of multidisciplinary expertise and has
experience bringing a variety of pharmaceutical and health care products to
market in the U.S.
and internationally. Members of the Company's Scientific Advisory Board are
among the world's leading experts in pulmonary medicine. Together, this
leadership team is pioneering important advancements in the pulmonary
pharmaceutical industry and positioning Aradigm as a new leader in the
specialty pharmaceutical market.
Executive Management
|
|
|
Igor Gonda,
Ph.D.
President
& Chief Executive Officer
Dr. Gonda has served as President and Chief Executive
Officer since August 2006, and as a director since September
2001. From December 2001 to August 2006, Dr. Gonda was
the Chief Executive Officer and Managing Director of Acrux
Limited, a publicly traded specialty pharmaceutical company
located in Melbourne,
Australia.
From July 2001 to December 2001, Dr. Gonda was our Chief
Scientific Officer and, from October 1995 to July 2001,
was our Vice President, Research and Development. From
February 1992 to September 1995, Dr. Gonda was a Senior
Scientist and Group Leader at Genentech, Inc. leading
inhalation development of products for severe respiratory
disease. Prior to that, Dr. Gonda held academic positions
at the University
of Aston in Birmingham, United Kingdom,
and the University of Sydney, Australia. Dr. Gonda holds
a B.Sc. in Chemistry and a Ph.D. in Physical Chemistry
from Leeds University,
United Kingdom.
Dr. Gonda was the Chairman of our Scientific Advisory
Board until August 2006. |
| |
|
|
|
|
|
Nancy
Pecota
Chief Financial Officer
Ms. Pecota has more than 20 years of experience in corporate
accounting and operations management. She previously served
as Chief Financial Officer for NuGEN Technologies, Inc.,
a life sciences tools company that provides specialty
reagents to pharmaceutical and diagnostics companies.
Prior to that she served as a financial consultant to
early- and mid-stage life sciences companies, developing
fundable business models and assessing and improving internal
financial preparation and reporting processes. She has
served as Vice President, Finance and Administration at
Signature BioScience, Inc., a venture-backed biopharmaceutical
company; and as Director, Finance and Accounting for ACLARA
BioSciences, Inc., a biotechnology company. Ms. Pecota
holds a Bachelor of Science in Economics from San Jose
State University and was among the executives named in
the San Francisco Business Times "100 Most Influential
Bay Area Business Women" in 2002 and 2003.
|
| |
|
|
| |
|
|
Board of Directors
Virgil D. Thompson
Chairman of the Board, Aradigm Corporation;
CEO of Spinnaker Biosciences, Inc.
Frank H. Barker
Former Group Chairman, Johnson & Johnson
Igor Gonda, Ph.D.
President & Chief Executive Officer, Aradigm Corporation
Dr. John M. Siebert
Former Chairman & Chief Executive Officer, CyDex, Inc.;
Former CEO of CIMA Labs
Tamar Howson
JSB-Partners, LP; former Senior Vice President of Corporate
and Business Development
at Bristol-Myers Squibb Company; former Senior Vice President
and Director of Business Development at SmithKline Beecham
Scientific Advisory
Board
Aradigm's Scientific Advisory Board is a highly regarded team
of scientific experts who help the Company with strategic input
into the development of treatments for severe respiratory disease,
hormonal and metabolic disorders, and in pharmaceutical development
and pulmonary drug delivery in general. The group assists the
Company on a variety of issues related to potential product
applications, product development paths and clinical testing.
Peter R.
Byron,
Ph.D.
Medical College of Virginia, Virginia
Commonwealth University
Expertise: Aerosol Science/Pharmaceutics
Peter S. Creticos, M.D.
The Johns Hopkins University School of Medicine
Expertise: Allergy/Immunology/Asthma
Stephen J. Farr, Ph.D.
Zogenix, Inc.
Expertise: Pulmonary Delivery/Pharmaceutics
Michael Konstan, M.D.
Rainbow Babies and Children’s Hospital
Expertise:Pulmonary Diseases/Cystic Fibrosis
Tunde
Otulana , M.D.
Aerovance, Inc.
Expertise: Pulmonary Diseases/Cystic Fibrosis/Regulatory
Adam Wanner,
Ph.D.
University of Miami
Expertise: Chronic Obstructive Pulmonary Diseases (COPD)
Martin Wasserman,
Ph.D.
Roche, Athero-Genics (retired)
Expertise: Asthma
In
addition to this Scientific Advisory Board, the Company also
engages other scientific and medical experts to assist on issues
specific to particular indications and programs.
|
